OBJECTIVE: Several studies have shown that obese children and adolescence seem to have an increased risk to develop a disturbed glucose metabolism as already known for obese adults. This might result in the same disastrous outcomes of cardiovascular diseases as it has been shown for adult obese patients. The most sensitive measurement for detecting changes in glucose metabolism in obese children seems to be an oral glucose tolerance test (OGGT) which is not practical for all daily outpatient clinics. DESIGN: Cross-sectional study.
In adults, the progression from normal to impaired glucose tolerance (IGT) and to type 2 diabetes is caused by insulin resistance followed by decreased B-cell insulin-secreting capacity. IGT harbours risk factors for cardiovascular disease. 10, 11 Recently, it has been shown that with changes in lifestyle progression from IGT to type 2 diabetes can be prevented or delayed. 12 Severe obesity in childhood is a major risk factor in the pathogenesis of type 2 diabetes, but it
is not yet clear which other clinical, biochemical or genetic factors determine manifestation. Therefore, we investigated the prevalence of type 2 diabetes, IGT and cardiovascular risk factors in a multiethnic European cohort of severely obese children and adolescents. Based on these results, we critically analyzed the recommended screening methods for the diagnosis of impaired glucose regulation.
Methods

Study population
We examined a cohort of 491 obese children and adolescents (age 7-18 y) of a multiethnic European origin for endocrine and metabolic abnormalities. Patients with obesity syndromes and other illnesses were excluded from this study. All 489 patients underwent a standard baseline diagnostic procedure including HDL-, LDL-, total cholesterol and triglyceride levels as well as baseline levels of T3, T4 and TSH.
We selected a high-risk group from this cohort according to the criteria of the American Diabetes Association (ADA) for type 2 diabetes screening in children and adolescents. 13 The ADA recommends that children and adolescents should be tested for type 2 diabetes if they are obese and display at least one other risk factor, such as a positive family history of type 2 diabetes and signs of insulin resistance (acanthosis nigricans, dyslipidemia, hypertension, polycystic ovary syndrome or an ethnic predisposition). 13 These criteria were met by 51 boys and 51 girls (Table 1) who underwent a 2-h oral glucose tolerance test (OGTT). None of the other patients had an impaired fasting glucose or elevated HbA1c level.
Body weight was measured with a digital scale (Soehnle, Germany) to the nearest 0.1 kg, and height was measured with a wall-mounted stadiometer (Keller, Germany). The body mass index (BMI) was calculated (the weight in kilograms divided by the square of the height in meters). All subjects had a BMI over the 97th percentile for age and sex and were thus classified as obese. The degree of obesity was quantified using Cole's least mean square method, which normalizes the BMI skewed distribution and expresses BMI as an standard deviation score (SDS-BMI). 14, 15 Blood pressure was measured in a supine position after 5 min rest to the nearest 2 mmHg using a Dinamap s model and results were interpreted using percentiles for age and sex. 16 Pubertal status was assessed according to the criteria of Tanner. 17, 18 None of the subjects was taking any medications.
Oral glucose tolerance test
The 102 subjects selected because of a high risk for type 2 diabetes followed a diet consisting of at least 250 g of carbohydrates per day for 3 days before the study. After a 12 h overnight fast, these subjects underwent an OGTT at 0800 hours. Baseline samples were obtained for measurement of fasting (venous) glucose, fasting insulin, testosterone, thyroid hormones and lipids. Glucose was given orally (1.75 g/kg, up to a maximum of 75 g glucose).
Blood samples were drawn after 30, 60, 90 and 120 min.
Glucose and insulin concentrations were determined, and categorized using World Health Organization (WHO). 19 Impaired fasting glucose was defined as fasting plasma glucose of 110-125 mg/dl (6.1-6.9 mmol/l) (equals 100-109 mg/dl in venous whole blood). IGT was defined as a 2-h plasma glucose level of 140-199 mg/dl (equals 120-179 mg/dl in venous whole blood); type 2 diabetes was defined as a fasting glucose level of 126 mg/dl (7 mmol/l) (equals 110 mg/dl in venous whole blood) or higher or a 2-h plasma glucose level of 200 mg/dl (11 mmol) (180 mg/dl in venous whole blood) or higher. 20 
Biochemical analysis
Glucose was measured by the glucose oxidase method on venous whole blood immediately deproteinized with perchloric acid. The obtained values were transformed into plasma glucose values in order to calculate the insulin resistance index (HOMA) and the insulin sensitivity index (ISI) by adding 10% to the venous whole blood glucose level. The lipid levels were determined by an enzymatic colorimetric test (analyser 704/717 Roche-Hitachi). The thyroid hormones and testosterone were measured with a fluoroimmunoassay (AutoDELFIA s ). Insulin was measured with a radioimmunoassay (Pharmacia). The crossreactivity with C-peptide was o0.18% and with proinsulin 41%.
The intra-assay variation was 5.8% for insulin and the interassay variation was 7%.
Calculations
Two approaches were used to characterise insulin sensitivity:
(1) The homeostasis model assessment for insulin resistance index (HOMA-IR) 21 was estimated using the formula: expressed as the ratio of the increment in the insulin level to that in the glucose level during the first 30 min after the Impaired glucose tolerance and type 2 diabetes mellitus S Wiegand et al ingestion of glucose. In children and adolescents, the insulinogenic index correlates well with the early insulin response obtained during a hyperglycemic clamp study. 7 A low insulinogenic index predicts the development of diabetes in adults. 25, 26 Statistical analysis All values are expressed as means7s.e. Differences in the means of variables were tested using both parametric and nonparametric tests depending on the distribution of the variables. The OGTT data were analyzed using repeated measures analysis of variance. Time was treated as a repeated measures factor, and normal/pathologic glucose tolerance was used as a between-subject factor. Correlation analyses were conducted using Spearman's correlation coefficients or Pearson's correlation coefficients, depending once again on the distribution of the variables. A probability value of less than 0.05 was considered significant. SPSS version 11 (SPSS, Chicago, IL, USA) was used for analysis. The Ethic committee of the Humboldt University of Berlin approved the study. Written informed consent was obtained from the parents and the subjects.
Results
Prevalence of IGT and type 2 diabetes
In all, 36.3% of the children and adolescents (N ¼ 37) had an IGT (Table 2 ). In 5.9% (N ¼ 6), type 2 diabetes was diagnosed. Among the children and adolescents with IGT, 86% were Caucasian and 14% were non-Caucasian. Four Caucasian Impaired glucose tolerance and type 2 diabetes mellitus S Wiegand et al adolescents and two non-Caucasian adolescents had type 2 diabetes.
Glucose and insulin responses to an oral glucose challenge Results of the OGTT in 102 children and adolescents are summarized for insulin and blood glucose (Figure 1 ). Insulin and glucose values changed significantly over time (Po0.0001). Fasting insulin levels (Table 2) were higher in children and adolescents with IGT or diabetes than in subjects with normal glucose tolerance. Furthermore, the insulin response to an oral glucose charge was elevated in children and adolescents with IGT as compared with the responses in those with normal glucose tolerance. The fasting blood glucose levels were higher in children and adolescents with IGT (90.371.2 mg/dl) than in those with normal glucose tolerance (86.670.7 mg/dl) (P ¼ 0.02). Similarly, at 120 min, glucose levels were higher in children and adolescents with IGT (124.771.7 mg/dl) than in those with normal glucose tolerance (97.671.7 mg/dl) (Po0.001) (Figure 1 ).
Early-phase insulin secretion
There were no significant differences in the early changes in the insulin level (within 30 min), glucose level or the insulinogenic index between children and adolescents with normal and IGT (Figure 2 ). In contrast, subjects with type 2 diabetes showed a significantly greater increase in the glucose level at 30 min compared with those that occurred in subjects either with IGT (P ¼ 0.05) or normal glucose tolerance (P ¼ 0.01). However, this increase in the glucose level at 30 min was not associated with a significant increase in insulin levels. Consequently, the calculated insulinogenic index was slightly but not significantly lower than that among subjects with normal and IGT (P ¼ 0.1).
Fasting glucose level vs 2-h glucose level: comparison of WHO and American diagnostic criteria
The ADA encourages the use of fasting glucose rather than the OGTT for the diagnosis of diabetes and impaired glucose regulation. 27 The WHO, however, recommends the OGTT as a screening procedure. 20 The differences in diagnostic criteria led to different results regarding prevalence rates. In this study, far more subjects were identified as having an impaired glucose regulation using WHO criteria compared to the ADA criteria. Four patients with type 2 diabetes would have been missed if only fasting blood glucose would have been employed as a diagnostic criteria (Table 3) .
Risk factors associated with insulin resistance and insulin sensitivity
The correlation between HOMA-IR and ISI was r ¼ À0.93 (Po0.0001). Both measures were strongly correlated with fasting insulin, with r ¼ 0.98 (Po0.0001) and r ¼ À0.9 (Po0.0001) for HOMA-IR and ISI, respectively. Both HOMA-IR and ISI were also correlated with the 2-h glucose level, with r ¼ 0.44 (Po0.0001) for HOMA-IR and r ¼ À0.55 (Po0.0001) for ISI. In addition HOMA-IR, ISI and fasting insulin were correlated to cardiovascular risk factors (Table 4) .
Nonparametric tests were used to compare differences in the means of HOMA-IR and ISI between different groups of children and adolescents.
Puberty. The study population was divided into a prepubertal group (Tanner stage I) and a group approaching or at puberty (Tanner stages II-V). Children at Tanner stage I (N ¼ 29) showed significantly lower values for HOMA-IR and higher values for ISI compared with children and adolescents at Tanner stage II-V (P ¼ 0.002 and P ¼ 0.007). Impaired glucose tolerance and type 2 diabetes mellitus S Wiegand et al
Sex. There were no significant differences between girls and boys with concern to insulin resistance or insulin sensitivity. However, girls with increased levels of total testosterone showed significantly higher values for HOMA-IR and lower values for ISI compared with girls with normal hormone levels (P ¼ 0.039 and P ¼ 0.045).
Acanthosis nigricans. The study population was divided into a group with and without acanthosis nigricans. Children and adolescents with this sign showed significantly higher values for HOMA-IR and lower values for ISI (P ¼ 0.001 and Po0.001).
Ethnic origin. Caucasian and non-Caucasian subjects showed similar HOMA-IR and ISI.
The insulin resistance syndrome We evaluated the degree to which children and adolescents show early risk factors for diabetes type 2 described as the insulin resistance syndrome. 28 In our study population of 102 obese children and adolescents, four showed all signs of the insulin resistance syndrome, that is, insulin resistance, hypertension, dyslipoproteinemia and increased uric acid. In 80% of the children and adolescents, at least two of these signs were present. In all, 43 of the obese children and adolescents suffered from an impaired glucose regulation (N ¼ 37 with IGT þ N ¼ 6 with type 2 diabetes). This group was analyzed separately: in 27 of these subjects (63%), other signs of the insulin resistance syndrome, such as hyperlipidemia, hypertension or elevated uric acid, were present. Fasting total cholesterol and fasting triglycerides were significantly higher and HDL-cholesterol significantly lower among the children and adolescents with IGT and diabetes than among those with normal glucose tolerance ( Table 2 ). No differences in systolic and diastolic blood pressure were observed between children and adolescents between the two groups.
Conclusions
Several studies have shown that obese children and adolescence seem to have an increased risk to develop a disturbed glucose metabolism as already known for obese adults. This might result in the same disastrous outcomes of cardiovascular diseases as it has been shown for adult obese patients. Therefore, obese pediatric patients need to be monitored for the occurrence of impaired glucose metabolism.
The most sensitive measurement for detecting changes in glucose metabolism in obese children seems to be an OGGT since Sinha et al 7 has shown a low prevalence of impaired fasting glucose in obese children and adolescents with IGT defined by OGGT (less than 0.08 vs 25%). The same conclusion was drawn by the DECODE study group for the diagnosis of IGT in adult obese patients. 29 However, the actual high prevalence of obesity in childhood populations makes it difficult to screen every obese child by an OGGT; a more practical approach is therefore warranted.
In order to test for a higher efficacy to diagnose impairments in glucose regulation, we estimated the prevalence of IGT by OGGT in a cohort of Caucasian obese children, which were preselected for the criteria suggested by the ADA as risk factors for type 2 diabetes, for example, a positive family history of type 2 diabetes and clinical signs of insulin resistance like acanthosis nigricans. The prevalence of IGT was compared to the prevalence defined by fasting glucose levels in the same individuals.
From a large number of children and adolescents (n ¼ 491) with obesity attending the outpatient department, we selected a high-risk group of 102 individuals according to the ADA criteria for diabetes screening.
In this group, a high prevalence of IGT was found based on OGGT (37%). In contrast, in the same group the fasting glucose level detected only 32% of the subjects with an IGT and only 33% of the patients with diabetes, which confirms the need to use the much more sensitive measurement of OGGT compared to fasting glucose.
In a recent study, Wabitsch et al have estimated the prevalence of IGT in a comparable obese pediatric cohort These data indicate that type 2 diabetes in adolescents is a still low but emerging problem in Europe and the US and seems not only to occur in ethnic minority groups 32 but also in multiethnic mostly Caucasian European populations. In general, during the course of occurrence of type 2 diabetes in obese individuals, during earlier time points increasing glucose responses are compensated by equally increased insulin responses. Later in the presence of diabetes, however, insulin secretion is no longer sufficient to compensate for extremely high glucose levels. This is also demonstrated by a lower insulinogenic index in children and adolescents with diabetes compared to those with normal or IGT. Therefore, also our data with lower insulinogenic index in the type 2 diabetes subjects compared to the IGT subjects suggests that while insulin resistance and IGT are already present, regular b-cell function is still preserved. These results are in accordance to those reported by Sinha et al. 7 There are associations between different features of the insulin resistance syndrome that suggests that a clustering of risk factors is present in obese children and adolescents. As part of the combined appearance of obesity related risk factors in our study population, children and adolescents with IGT presented also significantly elevated total cholesterol and triglyceride levels and lower HDL-cholesterol levels compared to children and adolescents with normal glucose tolerance. Furthermore, insulin resistance index was closely correlated with hypertriglyceridemia and the ISI with reduced HDL-cholesterol levels. Arslanian et al 33 described
correlations of basal insulin levels with VLDL and triglycerides in healthy lean children and adolescents. In her study, diastolic blood pressure was negatively correlated with insulin sensitivity. In our study, only the systolic blood pressure was negatively correlated with ISI.
In a recent study including obese African-American children aged 5-10 y, insulin resistance was inversely correlated with increases in blood pressure and triglycerides, but it was not correlated with LDL-or HDL-cholesterol. 34 Together, these data from different studies underline the concern that also in the pediatric obese cohorts the presence of several signs of the insulin resistance syndrome might predict that they are at increased risk of developing severe cardiovascular complications in the adult age. 35 Therefore, these patients should be considered as high-risk patients who need a close follow-up and intervention. In summary, these data indicate that also in Europe impaired glucose regulation and other signs of the insulin resistance syndrome in children and adolescents are far more common than so far believed and that is not restricted to ethnic minority groups. To identify these subjects, the pre-selection of a risk group according to the ADA criteria followed by OGGT might be more efficient and still sensitive compared to the screening of all obese children by OGGT. Irrespective of the methods to identify these children, their most likely increased risk to develop later on cardiovascular complications force us to diagnose them early enough and to refer them more consequently to a lifestyle modification and therapeutic intervention.
